Estimating vaccination coverage for the trivalent measles–mumps–rubella vaccine from trivariate serological data
- 24 February 2012
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 31 (14) , 1432-1449
Abstract
The effectiveness of childhood immunization programs depends on the vaccination coverage actually achieved. Routinely collected coverage data are not always available, and comparability between countries is often compromised because of different data collection methods. In 2000, Gay developed a method to estimate trivalent vaccination coverage from readily available trivariate serological data on the basis of parametric assumptions related to the rate of seroconversion for each vaccine component and probabilities of natural exposure to infection. Gay's work was indirectly published in a paper by Altmann and Altmann, who derived exact solutions for the parameters on the basis of Gay's modeling equations. In this paper, we propose a general likelihood‐based marginal model framework to extend Gay's model by relaxing two of its main assumptions. We use the Bahadur model for trivariate binary data to explicitly account for an association between the disease‐specific exposure probabilities. We fit several correlation structures to measles, mumps, and rubella serology from Belgium and Ireland. For both countries, we estimate a small positive pairwise exposure correlation, which improves the fit to the data. However, the effect on the estimated vaccination coverage and its associated variability is fairly moderate. For both Belgium and Ireland, all models reveal that the vaccination coverage achieved during the first 15 years since the introduction of measles, mumps, and rubella immunization is insufficient to eliminate measles. Copyright © 2012 John Wiley & Sons, Ltd.Keywords
Funding Information
- Institute for the Promotion of Innovation by Science and Technology in Flanders (060081)
- National Science Council of Taiwan (DP0881391)
This publication has 23 references indexed in Scilit:
- Persistence of Measles, Mumps, and Rubella Antibodies in an MMR‐Vaccinated Cohort: A 20‐Year Follow‐upThe Journal of Infectious Diseases, 2008
- Infant vaccination coverage in 2005 and predictive factors for complete or valid vaccination in Flanders, Belgium: an EPI-surveyVaccine, 2007
- Model selection methodology for inter-laboratory standardisation of antibody titresVaccine, 2005
- Outbreak of mumps in a vaccinated child population: a question of vaccine failure?Vaccine, 2004
- Immunogenicity of second dose measles–mumps–rubella (MMR) vaccine and implications for serosurveillanceVaccine, 2002
- Estimating vaccine coverage by using computer algebraMathematical Medicine and Biology: A Journal of the IMA, 2000
- Serologic status and measles attack rates among vaccinated and unvaccinated children in rural SenegalThe Pediatric Infectious Disease Journal, 1995
- Sustained Transmission of Mumps in a Highly Vaccinated Population: Assessment of Primary Vaccine Failure and Waning Vaccine-Induced ImmunityThe Journal of Infectious Diseases, 1994
- Measles Antibody: Reevaluation of Protective TitersThe Journal of Infectious Diseases, 1990
- Estimating the Dimension of a ModelThe Annals of Statistics, 1978